Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 286821 - 286840 out of 505060 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Italy | (L01EX07) cabozantinib | CABOMETYX*30 cpr riv 40 mg flacone | n/a | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell; Carcinomas, Hepatocellular | IPSENPHARMA |
| Italy | (L01EX07) cabozantinib | CABOMETYX*30 cpr riv 60 mg flacone | n/a | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell; Carcinomas, Hepatocellular | IPSENPHARMA |
| Italy | (L01EX08) lenvatinib | LENVIMA*30 cps 10 mg | n/a | Retail price with vat |
$0-0 |
$0-0 |
Thyroid Neoplasms | EISAIGMBH |
| Italy | (L01EX08) lenvatinib | LENVIMA*30 cps 4 mg | n/a | Retail price with vat |
$0-0 |
$0-0 |
Thyroid Neoplasms | EISAIGMBH |
| Italy | (L01EX09) nintedanib | OFEV*60x1 cps molli 100 mg | n/a | Retail price with vat |
$0-0 |
$0-0 |
Idiopathic Pulmonary Fibrosis | BOEHRINGERINGELHEIMINT.GMBH |
| Italy | (L01EX09) nintedanib | VARGATEF*120 cps molli 100 mg | n/a | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | BOEHRINGERINGELHEIMINT.GMBH |
| Italy | (L01EX09) nintedanib | OFEV*60x1 cps molli 150 mg | n/a | Retail price with vat |
$0-0 |
$0-0 |
Idiopathic Pulmonary Fibrosis | BOEHRINGERINGELHEIMINT.GMBH |
| Italy | (L01EX09) nintedanib | VARGATEF*60 cps molli 150 mg | n/a | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | BOEHRINGERINGELHEIMINT.GMBH |
| Italy | (L01EX10) midostaurin | RYDAPT*4x28 cps molli 25 mg | n/a | Retail price with vat |
$0-0 |
$0-0 |
Leukemia, Myeloid, Acute; Mastocytosis | NOVARTISEUROPHARMLTD |
| Italy | (L01EX13) gilteritinib | XOSPATA*84 cpr riv 40 mg | n/a | Retail price with vat |
$0-0 |
$0-0 |
Leukemia, Myeloid, Acute | ASTELLASPHARMAEUROPEB.V. |
| Italy | (L01EX17) capmatinib | TABRECTA*120 cpr riv 150 mg | n/a | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | NOVARTISEUROPHARMLTD |
| Italy | (L01EX17) capmatinib | TABRECTA*120 cpr riv 200 mg | n/a | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | NOVARTISEUROPHARMLTD |
| Italy | (L01EX18) avapritinib | AYVAKYT*30 cpr riv 100 mg flacone | n/a | Retail price with vat |
$0-0 |
$0-0 |
Gastrointestinal Stromal Tumors | BLUEPRINTMEDICINESB.V. |
| Italy | (L01EX18) avapritinib | AYVAKYT*30 cpr riv 200 mg flacone | n/a | Retail price with vat |
$0-0 |
$0-0 |
Gastrointestinal Stromal Tumors | BLUEPRINTMEDICINESB.V. |
| Italy | (L01EX18) avapritinib | AYVAKYT*30 cpr riv 25 mg flacone | n/a | Retail price with vat |
$0-0 |
$0-0 |
Gastrointestinal Stromal Tumors | BLUEPRINTMEDICINESB.V. |
| Italy | (L01EX18) avapritinib | AYVAKYT*30 cpr riv 300 mg flacone | n/a | Retail price with vat |
$0-0 |
$0-0 |
Gastrointestinal Stromal Tumors | BLUEPRINTMEDICINESB.V. |
| Italy | (L01EX18) avapritinib | AYVAKYT*30 cpr riv 50 mg flacone | n/a | Retail price with vat |
$0-0 |
$0-0 |
Gastrointestinal Stromal Tumors | BLUEPRINTMEDICINESB.V. |
| Italy | (L01EX22) selpercatinib | RETSEVMO*56 cps 40 mg | n/a | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung; Thyroid Neoplasms | ELILILLYNEDERLANDBV |
| Italy | (L01EX22) selpercatinib | RETSEVMO*112 cps 80 mg | n/a | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung; Thyroid Neoplasms | ELILILLYNEDERLANDBV |
| Italy | (L01EX22) selpercatinib | RETSEVMO*56 cps 80 mg | n/a | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung; Thyroid Neoplasms | ELILILLYNEDERLANDBV |
Pages
